Login to Your Account



World's First Regulated Neural Fetal Stem Cell Trial Under Way

By Nuala Moran


Wednesday, November 17, 2010
LONDON – ReNeuron Group plc reported that the first patient has been treated and discharged in the world's first regulated trial of a neural fetal stem cell therapy in the treatment of disability caused by ischemic stroke. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription